Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:LOBEF)

0.0348 -0.0002 (-0.57%)
Streaming Delayed Price Updated: 10:53 AM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 22,400
Open 0.0370
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0350
Today's Range 0.0348 - 0.0376
52wk Range 0.0082 - 0.0648
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
Via ACCESS Newswire
Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors
Via ACCESS Newswire

Performance

YTD
+74.0%
+74.0%
1 Month
-0.6%
-0.6%
3 Month
+58.2%
+58.2%
6 Month
+51.3%
+51.3%
1 Year
+148.6%
+148.6%

More News

Read More
Lobe Sciences Announces the Closing of the Previously Announced Private Placement
Via ACCESS Newswire
Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
Via ACCESS Newswire
Lobe Sciences Ltd. Announces Debt Settlement
Via ACCESS Newswire
Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
Via ACCESS Newswire
Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Via ACCESS Newswire
Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
Via ACCESS Newswire
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
Via ACCESS Newswire
Lobe Sciences Provides Corporate Update
Via ACCESS Newswire
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
From Lobe Sciences Ltd.
Via Business Wire
Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™
From Lobe Sciences, Ltd.
Via Business Wire
Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin™
From Lobe Sciences, Ltd.
Via Business Wire
Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.
From Lobe Sciences Ltd
Via Business Wire
Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team
From Lobe Sciences Ltd
Via Business Wire
Lobe Sciences Announces Update
From Lobe Sciences Ltd.
Via Business Wire
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
From Lobe Sciences Ltd.
Via Business Wire
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
From Lobe Sciences Ltd.
Via Business Wire
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
From Lobe Sciences Ltd.
Via Business Wire
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
From Lobe Sciences Ltd.
Via Business Wire
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Via Benzinga
Lobe Sciences Provides Company Review of 2023
From Lobe Sciences Ltd.
Via Business Wire
Lobe Sciences Provides Update on L-130 Clinical Program
From Lobe Sciences Ltd.
Via Business Wire
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
From Lobe Sciences Ltd.
Via Business Wire
Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia™ & Company
From Lobe Sciences Ltd.
Via Business Wire

Frequently Asked Questions

Is LOBEF publicly traded?
Yes, LOBEF is publicly traded.
What exchange does LOBEF trade on?
LOBEF trades on the OTC Traded
What is the ticker symbol for LOBEF?
The ticker symbol for LOBEF is LOBEF on the OTC Traded
What is the current price of LOBEF?
The current price of LOBEF is 0.0348
When was LOBEF last traded?
The last trade of LOBEF was at 09/17/25 10:53 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.